| |
|
|
| Name: |
Frazier Life Sciences Management L.P. |
| City: |
Menlo Park |
| State: |
CA |
| Zip: |
94025 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
55 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
MIRM |
Mirum Pharmaceuticals, Inc. |
1 |
- |
$0.00 |
$191,744,000 |
6,495,392 |
10.25% |
-12,720,000 |
25,000 |
17.617 |
N/A |
|
|
HLVX |
Hillevax, Inc. |
2 |
- |
$12.79 |
$156,993,000 |
9,781,472 |
8.39% |
25,432,000 |
0 |
29.26 |
N/A |
|
|
NAMS |
Newamsterdam Pharma Ord Shs |
3 |
- |
$0.00 |
$135,511,000 |
12,131,705 |
7.25% |
23,293,000 |
0 |
14.875 |
N/A |
|
|
KRYS |
Krystal Biotech Inc |
4 |
- |
$156.88 |
$122,628,000 |
988,460 |
6.56% |
7,967,000 |
0 |
3.968 |
N/A |
|
|
BBIO |
Bridgebio Pharma, Inc. |
5 |
- |
$24.88 |
$110,047,000 |
2,725,949 |
5.88% |
38,164,000 |
0 |
1.711 |
N/A |
|
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
6 |
- |
$38.28 |
$109,009,000 |
2,371,304 |
5.83% |
54,647,000 |
0 |
3.865 |
N/A |
|
|
PHAT |
Phathom Pharmaceuticals, Inc. |
7 |
- |
$0.00 |
$92,298,000 |
10,109,279 |
4.93% |
-12,535,000 |
0 |
29.626 |
N/A |
|
|
PCVX |
Vaxcyte, Inc. |
8 |
- |
$0.00 |
$73,125,000 |
1,164,405 |
3.91% |
13,764,000 |
0 |
1.08 |
N/A |
|
|
VRNA |
Verona Pharma Plc |
9 |
- |
$0.00 |
$59,925,000 |
3,014,349 |
3.2% |
10,791,000 |
0 |
4.11 |
N/A |
|
|
ALPN |
Alpine Immune Sciences Inc |
10 |
- |
$64.56 |
$59,677,000 |
3,131,008 |
3.19% |
25,490,000 |
145,251 |
6.82 |
N/A |
|
|
APLS |
Apellis Pharmaceuticals Inc |
11 |
- |
$49.86 |
$52,986,000 |
885,165 |
2.83% |
29,628,000 |
271,122 |
0.773 |
N/A |
|
|
RCKT |
Rocket Pharmaceuticals |
12 |
- |
$21.98 |
$45,645,000 |
1,523,013 |
2.44% |
16,897,000 |
120,000 |
1.934 |
N/A |
|
|
IRON |
Disc Medicine, Inc |
13 |
- |
$27.55 |
$45,342,000 |
785,000 |
2.42% |
14,570,000 |
130,000 |
4.509 |
N/A |
|
|
KALV |
Kalvista Pharmaceuticals Inc |
14 |
- |
$10.78 |
$44,373,000 |
3,622,294 |
2.37% |
13,183,000 |
383,435 |
10.729 |
N/A |
|
|
TARS |
Tarsus Pharmaceuticals, Inc. |
15 |
- |
$0.00 |
$36,197,000 |
1,787,527 |
1.94% |
4,433,000 |
0 |
6.702 |
N/A |
|
|
EWTX |
Edgewise Therapeutics, Inc. |
16 |
- |
$0.00 |
$29,179,000 |
2,667,203 |
1.56% |
24,314,000 |
1,818,181 |
3.821 |
N/A |
|
|
RVMD |
Revolution Medicines, Inc. |
17 |
- |
$35.96 |
$28,607,000 |
997,455 |
1.53% |
997,000 |
0 |
0.871 |
N/A |
|
|
ANTX |
An2 Therapeutics Ord Shs |
18 |
- |
$2.32 |
$28,458,000 |
1,388,889 |
1.52% |
6,125,000 |
0 |
7.156 |
N/A |
|
|
ARQT |
Arcutis Biotherapeutics, Inc. |
19 |
- |
$8.47 |
$28,308,000 |
8,764,232 |
1.51% |
-17,805,000 |
80,000 |
11.669 |
N/A |
|
|
AVTE |
Aerovate Therapeutics, Inc. |
20 |
- |
$0.00 |
$27,266,000 |
1,204,867 |
1.46% |
10,916,000 |
0 |
4.545 |
N/A |
|
|
AUTL |
Autolus Therapeutics Plc |
21 |
- |
$4.00 |
$24,130,000 |
3,746,857 |
1.29% |
15,400,000 |
0 |
2.165 |
N/A |
|
|
MGNX |
Macrogenics Inc |
22 |
- |
$14.56 |
$23,104,000 |
2,401,704 |
1.24% |
14,701,000 |
598,500 |
3.908 |
Biotechnology |
|
|
ACAD |
Acadia Pharmaceuticals Inc |
23 |
- |
$16.71 |
$22,885,000 |
730,917 |
1.22% |
9,737,000 |
100,020 |
0.455 |
Biotechnology |
|
|
ETNB |
89bio, Inc. |
24 |
New |
$8.26 |
$22,340,000 |
2,000,000 |
1.19% |
22,340,000 |
2,000,000 |
2.684 |
N/A |
|
|
MRUS |
Merus Nv |
25 |
- |
$45.04 |
$20,528,000 |
746,479 |
1.1% |
2,926,000 |
0 |
1.749 |
N/A |
|
|
ORIC |
Oric Pharmaceuticals, Inc. |
26 |
- |
$0.00 |
$19,714,000 |
2,142,855 |
1.05% |
6,750,000 |
0 |
5.45 |
N/A |
|
|
ANAB |
Anaptysbio Inc |
27 |
- |
$21.00 |
$19,272,000 |
899,700 |
1.03% |
3,113,000 |
0 |
2.829 |
N/A |
|
|
SVRA |
Savara Inc |
28 |
- |
$4.41 |
$18,800,000 |
4,000,000 |
1.01% |
3,680,000 |
0 |
3.513 |
Biotechnology |
|
|
SLNO |
Soleno Therapeutics Inc |
29 |
- |
$0.16 |
$18,714,000 |
464,937 |
1% |
4,994,000 |
0 |
0.584 |
N/A |
|
|
CERE |
Cerevel Therapeutics Holdin... |
30 |
- |
$42.47 |
$16,663,000 |
393,000 |
0.89% |
8,084,000 |
0 |
0.251 |
N/A |
|
|
DCPH |
Deciphera Pharmaceuticals, ... |
31 |
- |
$14.65 |
$16,482,000 |
1,021,800 |
0.88% |
11,776,000 |
651,800 |
1.677 |
N/A |
|
|
MDGL |
Madrigal Pharmaceuticals Inc |
32 |
New |
$193.33 |
$16,059,000 |
69,406 |
0.86% |
16,059,000 |
69,406 |
0.419 |
Diagnostic Substances |
|
|
DYN |
Dyne Therapeutics, Inc. |
33 |
New |
$24.73 |
$15,758,000 |
1,184,840 |
0.84% |
15,758,000 |
1,184,840 |
2.078 |
N/A |
|
|
SLN |
Silence Therapeutics Adr Re... |
34 |
- |
$0.00 |
$15,306,000 |
881,173 |
0.82% |
6,644,000 |
0 |
2.956 |
N/A |
|
|
TYRA |
Tyra Biosciences, Inc. |
35 |
- |
$0.00 |
$14,216,000 |
1,026,420 |
0.76% |
60,000 |
-1,593 |
2.487 |
N/A |
|
|
CRNX |
Crinetics Pharmaceuticals, ... |
36 |
- |
$42.12 |
$14,142,000 |
397,483 |
0.76% |
-33,143,000 |
-1,192,448 |
0.685 |
N/A |
|
|
GPCR |
Structure Therapeutics Inc. |
37 |
New |
$38.94 |
$12,929,000 |
317,190 |
0.69% |
12,929,000 |
317,190 |
0.829 |
N/A |
|
|
ARVN |
Arvinas Holding Company, Llc |
38 |
- |
$32.37 |
$11,744,000 |
285,331 |
0.63% |
6,140,000 |
0 |
0.536 |
N/A |
|
|
COGT |
Cogent Biosciences, Inc. |
39 |
- |
$6.02 |
$11,732,000 |
1,995,267 |
0.63% |
-2,906,000 |
493,884 |
2.523 |
N/A |
|
|
AGIO |
Agios Pharmaceuticals Inc |
40 |
- |
$31.49 |
$11,651,000 |
523,166 |
0.62% |
4,424,000 |
231,164 |
0.757 |
N/A |
|
|
APGE |
Apogee Therapeutics, Inc. |
41 |
- |
$47.13 |
$11,176,000 |
400,000 |
0.6% |
2,656,000 |
0 |
1.076 |
N/A |
|
|
TRVI |
Trevi Therapeutics, Inc. |
42 |
- |
$0.00 |
$9,891,000 |
7,381,090 |
0.53% |
-5,110,000 |
500,000 |
12.318 |
N/A |
|
|
THRX |
Theseus Pharmaceuticals, Inc. |
43 |
- |
$0.00 |
$8,578,000 |
2,118,051 |
0.46% |
2,530,000 |
-130,143 |
4.983 |
N/A |
|
|
NTLA |
Intellia Therapeutics, Inc. |
44 |
- |
$20.76 |
$6,210,000 |
203,684 |
0.33% |
-230,000 |
0 |
0.227 |
N/A |
|
|
MRTX |
Mirati Therapeutics, Inc. |
45 |
New |
$58.70 |
$4,700,000 |
80,000 |
0.25% |
4,700,000 |
80,000 |
0.12 |
Biotechnology |
|
|
BLUE |
Bluebird Bio, Inc. |
46 |
- |
$0.92 |
$2,360,000 |
1,709,907 |
0.13% |
-2,838,000 |
0 |
1.671 |
Biotechnology |
|
|
GRTS |
Gritstone Oncology, Inc. |
47 |
- |
$0.81 |
$2,103,000 |
1,030,878 |
0.11% |
-358,000 |
-400,000 |
1.516 |
N/A |
|
|
ACRS |
Aclaris Therapeutics, Inc. |
48 |
- |
$1.20 |
$278,000 |
264,377 |
0.01% |
-1,533,000 |
0 |
0.357 |
N/A |
|
|
PASG |
Passage Bio, Inc. |
54 |
Closed |
$1.32 |
$0 |
0 |
0% |
-1,157,000 |
-1,758,219 |
0 |
N/A |
|
|
ELVN |
Enliven Therapeutics Ord Shs |
53 |
Closed |
$0.00 |
$0 |
0 |
0% |
-14,350,000 |
-1,050,483 |
0 |
N/A |
|
|
SNDX |
Syndax Pharmaceuticals Inc |
52 |
Closed |
$21.06 |
$0 |
0 |
0% |
-8,712,000 |
-600,000 |
0 |
N/A |
|
|
STRO |
Sutro Biopharma Inc |
51 |
Closed |
$3.42 |
$0 |
0 |
0% |
-2,707,000 |
-780,000 |
0 |
N/A |
|
|
REPL |
Replimune Group Inc |
50 |
Closed |
$6.42 |
$0 |
0 |
0% |
-6,617,000 |
-386,762 |
0 |
N/A |
|
|
ADCT |
ADC Therapeutics Sa |
49 |
Closed |
$4.34 |
$0 |
0 |
0% |
-1,477,000 |
-1,647,030 |
0 |
N/A |
|
|
PRTA |
Prothena Corp Plc |
55 |
Closed |
$20.87 |
$0 |
0 |
0% |
-6,171,000 |
-127,900 |
0 |
N/A |
|
